Long-term therapy of diabetes insipidus with oral benzothiadiazine and phthalimidine diuretics.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A F Lant.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
1. Previous work on the incorporation of inorganic phosphate (P(i)) into ATP has suggested reversal of the chemical reactions of the Na pump in human red cells. A study has now been made of the associated movements of Na and K.2. The efflux of K, and the influx and efflux of Na were measured. When the Ringer was without K, the loss of cell K was inhibited by ouabain, and the ouabain-sensitive component of K efflux (0.36 mu-equiv.ml.(-1).hr(-1)) required external Na.3. The exchange of Na was also inhibited by ouabain. When influx and efflux of Na were measured simultaneously in K-free Ringer there was an excess of ouabain-sensitive influx over efflux of about 0.36 mu-equiv.ml.(-1).hr(-1). This difference balanced the ouabain-sensitive K efflux, and was not found with 10 mM-external K. The Na and K movements appear to be coupled and to be mediated by reversal of the Na pump.4. The net uptake of Na sensitive to ouabain was 0.38 mu-equiv.ml.(-1).hr(-1) for red cells incubated in K-free Ringer, and the net loss of K under the same conditions was 0.58 mu-equiv.ml.(-1).hr(-1) in rough keeping with the unidirectional flux values.5. Oligomycin decreased Na influx and efflux to the same extent as ouabain.6. There appears to be a coupled downhill movement of Na and K that is abolished both by inhibitors of the Na pump and by external K which promotes normal transport of Na outwards and K inwards.
Serum concentrations of beta-alanine and l-histidine are compared in five normal adults after ingestion of the dipeptide carnosine (beta-alanyl-l-histidine) and after equivalent amounts of the constituent free amino acids. The results indicate that absorption is significantly more rapid after the ingestion of the amino acids than after the dipeptide. The use of the test in a case of Hartnup disease suggests that carnosine is taken up by intestinal cells as the dipeptide, but subsequent hydrolysis and delivery of the constituent amino acids to the portal blood is a slower process than transport of the free amino acids themselves.
The results of oral tolerance tests of two dipeptides and of their constitutent amino acids are compared in normal subjects and in a case of Hartnup disease. In the control subjects the rate of absorption of phenylalanine from phenylalanyl-phenylalanine and of tryptophan from glycyl-tryptophan was slower than after the equivalent amount of the free amino acids. Absorption of the two essential amino acids (tryptophan and phenylalanine) in the patient was almost zero after administration in the free form, but was much greater after the dipeptide. Results of experiments on absorption and hydrolysis of the two peptides in the rat small intestine are also reported. It is suggested that whereas normal subjects absorb essential amino acids by a dual mechanism of mucosal uptake of free amino acids and oligopeptides, nutrition in Hartnup disease is largely dependent on uptake of oligopeptides containing the amino acids affected by the intestinal transport defect of the disease.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
1. The ionic composition of human red cell ghosts and suspending Ringer solutions have been varied independently. Measurements were made of the incorporation of [(32)P]o-phosphate ((32)P(i)) into ATP associated with different concentration gradients of Na and K across the membrane.2. Some incorporation of (32)P(i) was always found irrespective of the ionic composition of ghosts or media. However, additional labelling of energy-rich phosphate occurred when low Na, high K ghosts were incubated in a high Na, K-free medium. This did not occur when there was only a gradient of either Na or K. Downhill movements of both Na into and K out of the ghosts were needed for the extra labelling.3. Even in the presence of suitable ionic gradients, the extra incorporation was prevented by ouabain or by adding a small amount of external K sufficient to facilitate normal operation of the Na pump.4. Increase in internal P(i) stimulated the incorporation.5. The results show that the conditions for forward and backward running of the ATPase system associated with the Na pump are such that both reactions cannot proceed optimally at the same time.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Enalapril, the ethyl ester of a potent angiotensin converting enzyme inhibitor, enalaprilat, was administered to healthy volunteers as a capsule containing 10 mg of the maleate salt, every 24h for eight doses. Serum profiles show little accumulation of enalaprilat following eight daily doses of enalapril maleate. An average effective half-life for accumulation of approximately 11h was calculated from urine data. Comparison of observed 24-h urinary recoveries of enalaprilat to predicted steady-state recovery indicates that an 'average' steady state for enalaprilat is attained by the third or fourth dose of enalapril maleate. Statistical comparison of daily urinary recoveries, as well as Cmin values for enalaprilat, confirm this. Observed fluctuations in serum and urine data during apparent steady state suggest some day-to-day variability in the absorption of enalapril maleate and/or its hydrolysis to enalaprilat. An accumulation ratio of 1.3 for enalaprilat was calculated from the predicted steady-state urinary recovery and observed urinary recovery for dose one.
The effect of short term (7 days) and long term (28 days) pretreatment with the imidazole H2-receptor antagonist, cimetidine (CMT), on the pharmacokinetics of 5-fluorouracil (5-FUra) has been studied in the rat and cynomolgus monkey. Short-term pretreatment of rats with CMT significantly increased t1/2.z by 29 per cent and AUC by 40 per cent: total body clearance was decreased by 30 per cent. Long-term pretreatment exaggerated these effects. By contrast, short- and long-term pretreatment with the furan H2-receptor antagonist, ranitidine, caused no significant effect on 5-FUra kinetics. In the monkey, 7 days pretreatment with CMT increased t1/2.z by 32 per cent leaving other 5-FUra kinetic parameters unchanged; 28 days pretreatment increased both t1/2.z by 41 per cent and AUC by 100 per cent with a decrease in total body clearance of 5-FUra of 48 per cent. CMT, but not RNT, inhibited cytosolic dihydropyrimidine dehydrogenase (DPD), the enzyme responsible for 5-FUra catabolism. It is proposed that the observed effects of CMT on 5-FUra kinetics are the result of inhibition of DPD. This interaction has the potential for increasing systemic drug toxicity and it is therefore advisable that where H2-receptor blockade is administered concurrently with 5-FUra that a non-imidazole based H2-receptor antagonist such as RNT should be substituted for CMT.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.